InsiderTrades

Form 4 for EIKN Eikon Therapeutics, Inc.

Accepted 2026-02-10 00:00:00 ET · period of report 2026-02-06 · accession 0001193125-26-044903 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DI 2026-02-10 2026-02-06 EIKN PERLMUTTER ROGER M See remarks, Dir C - Cnv Deriv — +284.9K 284.9K New —
DMI 2026-02-10 2026-02-06 EIKN PERLMUTTER ROGER M See remarks, Dir C - Cnv Deriv — -2.12M 0 -100% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-02-06 C A 284,857 — 284,857 I See Footnote — — (F1) The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's initial public offering ("IPO") on a 1-for-7.4578 basis and had no expiration date. (F2) The Series D Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. (F3) The securities are held indirectly by the Reporting Person through Perlmutter Consulting, Inc. for the benefit of the Reporting Person. The Reporting Person had the sole pecuniary interest in the securities.
2 Derivative Series D Preferred Stock 2026-02-06 C D 855,512 — 0 I See Footnote — · — to — 114,714 Common Stock (F2) The Series D Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. (F3) The securities are held indirectly by the Reporting Person through Perlmutter Consulting, Inc. for the benefit of the Reporting Person. The Reporting Person had the sole pecuniary interest in the securities.
3 Derivative Series A-1 Preferred Stock 2026-02-06 C D 1,268,891 — 0 I See Footnote — · — to — 170,143 Common Stock (F1) The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's initial public offering ("IPO") on a 1-for-7.4578 basis and had no expiration date. (F3) The securities are held indirectly by the Reporting Person through Perlmutter Consulting, Inc. for the benefit of the Reporting Person. The Reporting Person had the sole pecuniary interest in the securities.